Company Overview
Tecogen Inc., together with its subsidiaries, designs, manufactures, markets, and maintains cogeneration products for multi-family residential, commercial, recreational, and industrial use in the United States. It operates in three segments: Products, Services, and Energy Production. The Products segment designs, manufactures, and sells industrial and commercial cogeneration systems to hospitals and nursing homes, schools and universities, health clubs and spas, hotels and motels, office and retail buildings, food and beverage processors, multi-unit residential buildings, laundries, ice rinks, swimming pools, factories, municipal buildings, indoor agriculture, military installations, and indoor growing facilities; and refrigeration compressors for cold storage, wineries, dairies, ice rinks, and food processing industries. Its Services segment provides operations and maintenance services; and parts sales, and installation services. The Energy Production segment installs, operates, and maintains distributed own generation electricity systems and sells the energy generated by such systems in the form of electricity, heat, hot water, and cooling to its customers under long-term energy sales agreements. The company also offers natural gas-powered cogeneration systems for water and space heating, and/or air conditioning. Its product portfolio includes InVerde e+ and TecoPower cogeneration units for the supply electricity and hot water; Tecochill, an air-conditioning and refrigeration chiller, and hybrid-drive air-cooled and gas engine-driven chiller to produce chilled water and hot water; Tecofrost, a gas engine-driven refrigeration compressor to circulate refrigerant and provide hot water as a byproduct; and Ultera, an emissions control technology. It sells its products through in-house marketing, as well as independent sales agents and representatives. Tecogen Inc. was incorporated in 2000 and is headquartered in North Billerica, Massachusetts.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.15.
Recent Developments
- Dec 2025 Revenue of $27.07M (+19.7% YoY); net profit $-8.25M.
- Trailing 12 Months Year-on-year growth — revenue -21.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 7.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 7.13% |
| 1 Year: | -21.20% |
Stock Price Performance
| 1 Year: | -62.49% |
| 6 Months: | +10.62% |
| 3 Months: | -46.96% |
| 1 Month: | -16.97% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.60 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 73.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Industrials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TGEN Tecogen Inc. | 3.23 | -8.97 | $97.51M | 0.00% | -25.72% | -78.34% | 7.13% | - |
| 2 | SPCX Space Exploration Technologies Corp. R3KAIDEFENCE | 153.47 | -139.52 | $1.16T | 0.00% | -3.22% | -11.95% | 34.08% | -3.34% |
| 3 | CAT Caterpillar Inc. SPXR3K | 822.48 | 35.47 | $378.07B | 0.79% | 17.98% | 56.97% | 2.29% | 5.24% |
| 4 | GE GE Aerospace SPXR3KDEFENCE | 334.91 | 39.40 | $347.49B | 0.60% | 9.52% | 48.23% | -7.42% | -5.36% |
| 5 | RTX RTX Corporation SPXR3KDEFENCE | 198.81 | 35.06 | $267.95B | 1.51% | 8.28% | 12.27% | 2.61% | 2.62% |
| 6 | GEV GE Vernova Inc. SPXR3KAI | 971.31 | 27.86 | $258.69B | 0.22% | 6.30% | 82.58% | 8.68% | - |
| 7 | DE Deere & Company SPXR3K | 680.73 | 37.88 | $183.54B | 0.95% | 12.53% | 18.24% | 3.43% | 5.10% |
| 8 | UNP Union Pacific Corporation SPXR3K | 288.45 | 23.38 | $171.36B | 2.01% | 15.22% | 39.70% | 2.30% | 7.77% |
| 9 | BA The Boeing Company SPXR3KDEFENCE | 210.73 | 75.80 | $166.43B | 0.00% | -9.01% | - | 1.67% | -3.28% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2013 | Sep 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.45M | 7.94M | 8.18M | 7.87M | 8.67M | 7.96M | 7.44M | 7.20M | 6.06M | 6.15M | 5.02M | 7.44M | 6.41M | 6.62M | 5.38M | 6.75M | 7.11M | 6.19M | 4.73M | 5.63M | 7.28M | 7.29M | 7.18M | 5.32M | 6.34M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.06M | 4.83M | 5.00M | 3.36M | 3.75M |
| Gross Profit | 813.87K | 1.09M | 1.43M | 1.35M | 1.09M | 2.14M | 2.14M | 1.67M | 1.72M | 2.10M | 2.77M | 2.91M | 2.99M | 3.26M | 3.84M | 3.16M | 2.88M | 2.96M | 3.43M | 2.83M | 2.79M | 2.91M | 2.79M | 2.95M | 2.84M | 2.34M | 3.09M | 2.70M | 2.89M | 2.09M | 2.83M | 2.93M | 2.58M | 2.08M | 2.48M | 3.22M | 2.46M | 2.18M | 1.96M | 2.59M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.82M | 3.87M | 4.28M | 4.98M | 4.72M |
| Operating Income | -1.15M | -1.41M | -1.05M | -1.22M | -1.46M | -302.31K | -302.31K | -923.75K | -906.87K | -386.03K | 249.49K | 77.70K | -245.86K | 85.54K | 70.91K | -636.29K | -562.31K | -3.35M | -334.58K | -538.18K | -1.12M | -499.90K | -207.16K | -139.00K | -309.57K | -910.17K | 80.98K | -817.34K | -214.30K | -1.45M | -780.25K | -368.29K | -1.05M | -1.47M | -873.22K | -594.24K | -1.41M | -2.10M | -3.03M | -2.13M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -441.54K | -1.21M | -1.84M | -3.70M | -1.81M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.33K | 38.15K | 41.11K | 38.70K | 34.24K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -659.56K | -1.46M | -2.12M | -4.00M | -2.11M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 925 | 16.76K | 2.93K | 0 | 10.90K |
| Net Income | -1.09M | -1.39M | -1.02M | -1.23M | -1.45M | -362.84K | -362.84K | -948.84K | -893.17K | -415.54K | 207.87K | 44.79K | -293.54K | 27.21K | 20.76K | -754.35K | -603.04K | -3.28M | -357.13K | -586.25K | -1.20M | -653.89K | -231.92K | 1.77M | 399.63K | 1.47M | 89.41K | -856.22K | -256.71K | -1.49M | -780.11K | -481.57K | -1.10M | -1.54M | -930.41K | -659.92K | -1.46M | -2.13M | -3.99M | -2.12M |
| Diluted EPS | - | - | - | - | - | - | - | -0.06 | -0.05 | - | 0.01 | 0.00 | - | 0.00 | 0.00 | - | -0.02 | -0.13 | - | - | -0.05 | -0.03 | -0.01 | 0.07 | 0.02 | 0.06 | 0.00 | -0.03 | -0.01 | -0.06 | -0.03 | -0.02 | -0.04 | -0.06 | -0.04 | -0.03 | -0.06 | -0.07 | -0.13 | -0.07 |
| R&D Expense | 260.26K | 260.26K | 308.13K | 251.58K | 329.52K | 228.32K | 228.32K | 206.22K | 218.96K | 151.66K | 154.07K | 180.61K | 218.72K | 241.72K | 302.23K | 409.78K | 281.09K | 345.08K | 372.55K | 365.82K | 364.34K | 166.03K | 111.25K | 126.15K | 132.88K | 122.03K | 140.13K | 194.85K | 202.14K | 229.10K | 236.56K | 160.03K | 254.70K | 246.49K | 233.81K | 292.67K | 268.72K | 297.93K | - | 363.82K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.07M | 15.25M | 15.85M | 19.34M | 21.44M | 24.49M | 33.20M | 35.88M | 33.43M | 28.25M | - | 25.00M | 25.14M | 22.62M | 27.07M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | 13.94M | 14.94M | 12.75M | 17.25M |
| Gross Profit | 4.89M | 5.87M | 5.03M | 6.40M | 7.63M | 9.30M | 12.95M | 13.59M | 12.48M | 10.83M | - | 11.07M | 10.20M | 9.87M | 9.82M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | 13.45M | 14.65M | 14.20M | 16.96M |
| Operating Income | -1.88M | -2.00M | -3.67M | -3.70M | -2.64M | -997.45K | 225.15K | -5.54M | -4.66M | -5.96M | - | -2.39M | -4.45M | -4.33M | -7.13M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | -1.90M | -3.85M | -3.98M | -7.20M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | 50.97K | 77.05K | 117.12K | 150.29K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | -2.38M | -4.49M | -4.65M | -8.23M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | 16.35K | 32.49K | 22.57K | 20.61K |
| Net Income | -1.57M | -1.64M | -3.45M | -3.75M | -2.73M | -1.10M | 47.44K | -5.71M | -4.71M | -6.15M | - | -2.45M | -4.60M | -4.76M | -8.25M |
| Diluted EPS | - | - | - | - | - | -0.06 | 0.00 | -0.23 | - | -0.25 | - | -0.10 | -0.19 | -0.19 | -0.30 |
| R&D Expense | - | 431.00K | 1.09M | 1.04M | 591.59K | 667.06K | 936.93K | 1.30M | 1.46M | 767.32K | 542.08K | 732.87K | 840.01K | 961.84K | 1.17M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 8.75M | 9.12M | 17.63M | 14.12M | 21.09M | 23.74M | 50.67M | 49.90M | 41.12M | 30.07M | - | 28.25M | 27.79M | 31.09M | 36.99M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | 22.03M | 20.31M | 22.15M | 28.89M |
| Cash & Equivalents | 1.83M | 3.02M | 1.57M | 7.71M | 1.19M | 5.49M | 3.72M | 1.67M | 272.55K | 877.68K | 1.49M | - | 1.91M | 1.35M | 5.41M | 12.43M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | 10.48M | 10.55M | 9.63M | 10.95M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | 6.71M | 6.74M | 6.03M | 4.28M |
| Total Liabilities | - | 3.52M | 4.33M | 10.56M | 8.30M | 8.65M | 9.23M | 16.98M | 21.87M | 17.76M | 12.81M | - | 9.27M | 13.14M | 20.97M | 15.52M |
| Current Liabilities | - | 3.15M | 4.19M | 10.36M | 5.09M | 5.38M | 5.62M | 8.71M | 13.20M | 13.45M | 9.17M | - | 7.69M | 10.48M | 16.82M | 9.27M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | 1.31M | 1.48M | 3.73M | 2.82M |
| Total Equity | 2.99M | 5.07M | 4.61M | 7.27M | 6.15M | 12.84M | 14.51M | 33.24M | 27.78M | 23.27M | 17.31M | - | 19.09M | 14.75M | 10.23M | 21.65M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | 24.85M | 24.85M | 24.95M | 29.85M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.41M | -3.15M | -3.38M | -5.13M | -4.73M | -2.72M | -591.26K | -3.86M | -4.48M | 1.41M | - | -1.35M | -817.81K | 4.06M | -9.91M |
| Investing Cash Flow | -748.93K | 122.34K | -916.39K | -942.84K | -185.74K | -2.26M | 1.51M | 1.28M | 4.71M | -217.76K | - | -348.56K | -244.89K | -1.01M | -464.13K |
| Financing Cash Flow | 4.35M | 1.58M | 10.44M | -458.21K | 9.22M | 3.21M | -2.97M | 1.18M | 382.90K | -576.93K | - | 0 | 500.00K | 1.01M | 17.40M |
| Capital Expenditure | -115.19K | -219.71K | -202.70K | -223.57K | -69.58K | -139.72K | -580.04K | -828.09K | -95.64K | -59.95K | - | -344.38K | -46.85K | -969.16K | -400.78K |
| Free Cash Flow | -2.52M | -3.37M | -3.59M | -5.35M | -4.80M | -2.86M | -1.17M | -4.69M | -4.58M | 1.35M | - | -1.70M | -864.66K | 3.09M | -10.31M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | -1.70M | -562.70K | 4.05M | 7.03M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 44.2% | 38.4% | 31.7% | 33.1% | 35.6% | 38.0% | 39.0% | 37.9% | 37.3% | 38.3% | - | 44.3% | 40.6% | 43.6% | 36.3% |
| Operating Margin % | -17.0% | -13.1% | -23.2% | -19.1% | -12.3% | -4.1% | 0.7% | -15.4% | -13.9% | -21.1% | - | -9.5% | -17.7% | -19.1% | -26.3% |
| Net Margin % | -14.2% | -10.7% | -21.8% | -19.4% | -12.7% | -4.5% | 0.1% | -15.9% | -14.1% | -21.8% | - | -9.8% | -18.3% | -21.0% | -30.5% |
| ROE % | -31.0% | -35.5% | -47.4% | -60.9% | -21.2% | -7.6% | 0.1% | -20.5% | -20.2% | -35.5% | - | -12.8% | -31.2% | -46.5% | -38.1% |
| ROCE % | -33.6% | -40.7% | -50.5% | -41.0% | -16.8% | -5.5% | 0.5% | -15.1% | -16.8% | -28.5% | - | -11.6% | -25.7% | -30.3% | -25.7% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Portolan Capital Management, LLC | 6.21% | 1.55M | $4.84M |
| 2 | Vanguard Capital Management LLC | 3.16% | 788.67K | $2.46M |
| 3 | Bard Associates Inc. | 2.73% | 682.22K | $2.13M |
| 4 | Clear Harbor Asset Management, LLC | 2.60% | 650.00K | $2.03M |
| 5 | Herald Investment Management Ltd | 1.68% | 420.00K | $1.31M |
| 6 | Gratia Capital, LLC | 1.56% | 388.66K | $1.21M |
| 7 | UBS Group AG | 1.45% | 363.05K | $1.13M |
| 8 | Meros Investment Management, Lp | 1.41% | 353.49K | $1.10M |
| 9 | Palisades Investment Partners, LLC | 1.29% | 323.09K | $1.01M |
| 10 | Susquehanna International Group, LLP | 1.26% | 315.83K | $985.39K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TGEN
Tecogen (TGEN) corrects general counsel’s 41,954-share stake - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOakpoNXZyalc3QmtRcmM3X2pmbDEtMDluRkk0Y0lsYVBtWDFEVUJ3ZjJxSVc2dzJNTU53WjFNSDFYa1ZHRk4xOXNrcHRvTWsycERPSVZ5Z0h3dXhtOGxubHZfOWRTOUZ5WkVrVjhaZXBWczNOaGlOOWRmN3RYS1FsbUlQMGZCZWFTc2ZfUE…
Tecogen (TGEN) corrects CFO stake after 29K-share grant - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPUEdDUlNERjlZM1ZRbHd6YV9lZlpnNlVBNVdnY1RDaldmT1VyT0tTQk5EMjJfWUE4OVliMGstWEVkT2R6a18zSHc5Y2Nlcm9GM1YxaHdmOHZ2WjVYRGlJZ2xMcVlUbG1FUVpKaXpNWEswS1hrcTRwRk1fQU03ZHhIcGtoeFFpNkdWdnA5YW…
Tecogen (TGEN) Stock Sees Fair Value Cut As Data Center Order Hopes Face Scrutiny - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxNYUFIQnpRTUxITkVtVnJWZndTazhLMjFCc19jb2Z2b3VhR3haOXBFUEROSzEzZFRhMUJFVzdVQ0dENEZOdTdFbEQtOG55QUZESmVaX0YyYW1GUlJMM01PR3I5Qk8xSlJ1ekxHZFFrcEtvdk5uSW5oa2podnpYLWFNXzViNmRDMVJ3aE9nc2…
Why Is TGEN Stock Rising After Hours? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNQWFoME9zNGRjcS1ZSDlrejVlUURZVWI4NUN0cEdvLUlJc3JodHlOWHlTRVRibWJsWDlMVjFURHIyazJxbzVhdnhSdng1ck03OVVvaVJnRWw3MmNRbV9nUFpabWVKeUNCLWhfSDNZSnNwUlc0NHE2LUEyOE5YTWpxQ3hsWVVpS0Etd185Wn…
Tecogen (TGEN) lifts COO stake with 9,671 free shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQWUxKU2prbUhUOTZ2Wl93ZjdaejlRQnFFalQ4VFVOZ1JwMFQ1cG9rTktiUkkwdi1HYlVCancwS2tsTjRlUGpwbjFPZmI2bnZTanBNOEpTR3pfelczZXZSazB5WFBpaWdPek1kLUhXN2ppYXhmMWwzY0J6OEIwQWFoM3RBNEpCeWdXemFZSF…
Tecogen Inc. (TGEN) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQdDBNRkNmTFE3MkdqSUxRODRmOWpNdjFWY0xWUTRoTFB1a0dGdVl1RjJSeE53WThBZ2VaWkthMXVlR2wxdFF5U3BHdk11LU05dzBBNG5yblQzM0NveFkyVU5vcFd0OVpITzM5cWk3LW9GWC1Sb0E1T1Z3R1VJYlFTVWZ5TXBzc3RSanZ0S2…
TGEN — Frequently Asked Questions
What is the current share price of Tecogen Inc. (TGEN)?
As of 2026-09-19 21:16 PDT, Tecogen Inc. (TGEN) trades at $3.23 on NYSE American. Its 52-week range is $2.00 to $12.07.
What is the market capitalisation of TGEN?
Tecogen Inc. (TGEN) has a market capitalisation of $97.51M on NYSE American.
What is the P/E ratio of TGEN?
TGEN trades at a trailing price-to-earnings (P/E) ratio of -8.97. The industry average P/E is 26.00. Its price-to-book (P/B) ratio is 5.32.
What is the return on equity (ROE) of TGEN?
TGEN has a return on equity (ROE) of -78.34%. Its return on capital employed (ROCE) is -25.72%.
Is TGEN a good stock to buy?
This page provides a data-driven analysis of Tecogen Inc. (TGEN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.